These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Chronic lymphatic leukemia: disorders of lymphocyte kinetics. Pathophysiological aspects and therapeutic consideration]. Bremer K Dtsch Med Wochenschr; 1975 May; 100(22):1250-5. PubMed ID: 1132340 [No Abstract] [Full Text] [Related]
7. [Treatment of chronic lymphatic leukemia with heterologous antilymphocytic serum. I. Obtaining of heterologous serum against lymphocytes of chronic lymphatic leukemia]. Jasser S; Pawelski S; Skowrońska H; Tupalska B; Brühlowa A Acta Haematol Pol; 1971; 2(1):17-25. PubMed ID: 5170673 [No Abstract] [Full Text] [Related]
8. [On chronic lymphatic leukemia and its therapy: study of 40 cases]. Baccarani M; Tura S; Ricci Bitti ML; Storti E; Gugliotta L; Ricci P; Lauria F; Bagnara GP; Staffa C; Pascucci E G Clin Med; 1970 Oct; 51(10):764-84. PubMed ID: 4108784 [No Abstract] [Full Text] [Related]
9. [Therapy of chronic lymphatic leukemia]. Theml H Verh Dtsch Ges Inn Med; 1973; 79():323-34. PubMed ID: 4790231 [No Abstract] [Full Text] [Related]
10. [Treatment of chronic lymphocytic leukemia]. Hoerni B; Simon G Bord Med; 1971 May; 4(5):1647-50. PubMed ID: 5569954 [No Abstract] [Full Text] [Related]
11. [Induction of tolerance of heterologous protein in therapy with antilymphocytic globulin in man]. Tilz GP Med Klin; 1972 Mar; 67(12):410-3. PubMed ID: 4112374 [No Abstract] [Full Text] [Related]
12. [Fine structure of circulating lymphocytes under the effect of antilymphocyte serum (ALS) in chronic lymphatic leukemia]. Hu D; Pfisterer H; Lani K Blut; 1970 May; 20(5):273-81. PubMed ID: 4986661 [No Abstract] [Full Text] [Related]
13. [Immunodepressive and immunostimulant effectiveness of bovine antilymphocyte gamma globulin for humans]. Antonenko VT; Timchenko AS Fiziol Zh; 1976; 22(5):651-5. PubMed ID: 789121 [No Abstract] [Full Text] [Related]